摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-methylphenyl 3,5-dimethyl-1-phenyl-1H-pyrazole-4-carboxylate

中文名称
——
中文别名
——
英文名称
4-methylphenyl 3,5-dimethyl-1-phenyl-1H-pyrazole-4-carboxylate
英文别名
(4-methylphenyl) 3,5-dimethyl-1-phenylpyrazole-4-carboxylate
4-methylphenyl 3,5-dimethyl-1-phenyl-1H-pyrazole-4-carboxylate化学式
CAS
——
化学式
C19H18N2O2
mdl
——
分子量
306.4
InChiKey
HWVVEWNZEAKFSL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    44.1
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Cyclic AMP-specific phosphodiesterase inhibitors
    申请人:ICOS Corporation
    公开号:US20030236412A1
    公开(公告)日:2003-12-25
    Pyrazole compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed.
    本发明公开了一种强效和选择性的PDE4抑制剂吡唑化合物,以及制备这些化合物的方法。本发明还公开了这些化合物在治疗炎症性疾病和其他涉及细胞因子平升高的疾病以及中枢神经系统(CNS)疾病中的应用。
  • PYRAZOLE CYCLIC AMP-SPECIFIC PDE INHIBITORS
    申请人:ICOS CORPORATION
    公开号:EP1248781A1
    公开(公告)日:2002-10-16
  • US6569885B1
    申请人:——
    公开号:US6569885B1
    公开(公告)日:2003-05-27
  • US7087634B2
    申请人:——
    公开号:US7087634B2
    公开(公告)日:2006-08-08
  • [EN] PYRAZOLE CYCLIC AMP-SPECIFIC PDE INHIBITORS<br/>[FR] INHIBITEURS DE LA PHOSPHODIESTERASE SPECIFIQUE DE L'ADENOSINE MONOPHOSPHATE CYCLIQUE PYRAZOLIQUE
    申请人:ICOS CORP
    公开号:WO2001046172A1
    公开(公告)日:2001-06-28
    Pyrazole compounds (I) that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed (I) wherein Y is O or NOH; Z is O or NH; R1 - R4 are as claimed.
查看更多